AAAAAA

   
Results: 1-8 |
Results: 8
A PHASE-I PHASE-II STUDY OF MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH G-CSF, OR G-CSF AND HEMATOPOIETIC PROGENITOR CELLS IN WHOLE-BLOOD, IN 2 CONSECUTIVE COHORTS OF PATIENTS/
Authors: DEWIT R KRUIT WHJ LAMERS CHJ VANTVEER MB LUYTEN AA VANBEURDEN V HARTEVELD M PLANTING AST SCHMITZ PIM STOTER G BOLHUIS RLH VERWEIJ J
Citation: R. Dewit et al., A PHASE-I PHASE-II STUDY OF MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY SUPPORTED WITH G-CSF, OR G-CSF AND HEMATOPOIETIC PROGENITOR CELLS IN WHOLE-BLOOD, IN 2 CONSECUTIVE COHORTS OF PATIENTS/, British Journal of Cancer, 77(12), 1998, pp. 2363-2366
PHASE-I AND PHARMACOLOGICAL STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: PRONK LC SCHELLENS JHM PLANTING AST VANDENBENT MJ HILKENS PHE VANDERBURG MEL DEBOERDENNERT M MA J BLANC C HARTEVELD M BRUNO R STOTER G VERWEIJ J
Citation: Lc. Pronk et al., PHASE-I AND PHARMACOLOGICAL STUDY OF DOCETAXEL AND CISPLATIN IN PATIENTS WITH ADVANCED SOLID TUMORS, Journal of clinical oncology, 15(3), 1997, pp. 1071-1079
THE BIOAVAILABILITY OF ORAL GI147211 (GG211), A NEW TOPOISOMERASE-I INHIBITOR
Authors: GERRITS CJH SCHELLENS JHM CREEMERS GJ WISSEL P PLANTING AST PRITCHARD JF DEPEE S DEBOERDENNERT M HARTEVELD M VERWEIJ J
Citation: Cjh. Gerrits et al., THE BIOAVAILABILITY OF ORAL GI147211 (GG211), A NEW TOPOISOMERASE-I INHIBITOR, British Journal of Cancer, 76(7), 1997, pp. 946-951
PHASE-II AND PHARMACOLOGICAL STUDY OF TOPOTECAN ADMINISTERED AS A 21-DAY CONTINUOUS-INFUSION TO PATIENTS WITH COLORECTAL-CANCER
Authors: CREEMERS GJ GERRITS CJH SCHELLENS JHM PLANTING AST VANDERBURG MEL VANBEURDEN VM DEBOERDENNERT M HARTEVELD M LOOS W HUDSON I STOTER G VERWEIJ J
Citation: Gj. Creemers et al., PHASE-II AND PHARMACOLOGICAL STUDY OF TOPOTECAN ADMINISTERED AS A 21-DAY CONTINUOUS-INFUSION TO PATIENTS WITH COLORECTAL-CANCER, Journal of clinical oncology, 14(9), 1996, pp. 2540-2545
PHASE-I AND PHARMACOLOGICAL STUDY OF THE NEW TOPOISOMERASE-I INHIBITOR GI147211, USING A DAILY X 5 INTRAVENOUS ADMINISTRATION
Authors: GERRITS CJH CREEMERS GJ SCHELLENS JHM WISSEL P PLANTING AST KUNKA R SELINGER K DEBOERDENNERT M MARIJNEN Y HARTEVELD M VERWEIJ J
Citation: Cjh. Gerrits et al., PHASE-I AND PHARMACOLOGICAL STUDY OF THE NEW TOPOISOMERASE-I INHIBITOR GI147211, USING A DAILY X 5 INTRAVENOUS ADMINISTRATION, British Journal of Cancer, 73(6), 1996, pp. 744-750
PHASE-II STUDY WITH TOPOTECAN (T) ADMINISTERED AS A 21-DAYS CONTINUOUS-INFUSION TO PATIENTS WITH COLORECTAL-CANCER
Authors: CREEMERS GJ GERRITS CHJ PLANTING AST SCHELLENS JHM VANDERBURG MEL DEBOERDENNERT M HARTEVELD M HUDSON I STOTER G VERWEIJI J
Citation: Gj. Creemers et al., PHASE-II STUDY WITH TOPOTECAN (T) ADMINISTERED AS A 21-DAYS CONTINUOUS-INFUSION TO PATIENTS WITH COLORECTAL-CANCER, European journal of cancer, 31A, 1995, pp. 700-700
A CENTRAL DOMAIN OF RHIZOBIUM NODE PROTEIN MEDIATES HOST-SPECIFICITY BY DETERMINING THE HYDROPHOBICITY OF FATTY ACYL MOIETIES OF NODULATIONFACTORS
Authors: BLOEMBERG GV KAMST E HARTEVELD M VANDERDRIFT KMGM HAVERKAMP J THOMASOATES JE LUGTENBERG BJJ SPAINK HP
Citation: Gv. Bloemberg et al., A CENTRAL DOMAIN OF RHIZOBIUM NODE PROTEIN MEDIATES HOST-SPECIFICITY BY DETERMINING THE HYDROPHOBICITY OF FATTY ACYL MOIETIES OF NODULATIONFACTORS, Molecular microbiology, 16(6), 1995, pp. 1123-1136
KINETICS OF 2,4-DICHLOROPHENOXYACETIC ACID CONTENT IN AN AUXIN-DEPENDENT SUSPENSION-CULTURE OF NICOTIANA-TABACUM CELLS
Authors: KOENS KB NICOLOSO FT VANVLIET TB HARTEVELD M BOOT CJM VANIREN F MULDER P LIBBENGA KR KIJNE JW
Citation: Kb. Koens et al., KINETICS OF 2,4-DICHLOROPHENOXYACETIC ACID CONTENT IN AN AUXIN-DEPENDENT SUSPENSION-CULTURE OF NICOTIANA-TABACUM CELLS, Journal of plant physiology, 147(3-4), 1995, pp. 383-390
Risultati: 1-8 |